clinical trial · NCT06974929
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.·phase2·recruiting·n = 80
Breast CancerHRS-6209 CapsulesLetrozole TabletsHRS-2189 Tablets
brief summary
This is a study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HRS-6209 combined with other treatment regimens in breast cancer patients, and preliminarily observe its anti-tumor efficacy.
started
May 22, 2025
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Jun 12, 2026
official title
An Open-Label, Multicenter Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HRS-6209 Combination Therapy in Patients With Breast Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol